Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 22, 2021
Seqens CDMO, a pharmaceutical manufacturer of new chemical entities (NCEs), active pharmaceutical ingredients (APIs) and other specialty chemical products, announced that Bob Huang has joined as Managing Director for North America. The company is a ...
read more
Wednesday, September 22, 2021
GeneQuine Biotherapeutics GmbH, a biotech company focused on the development of gene therapy for musculoskeletal disorders, announced that it has contracted Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO), to ...
read more
Tuesday, September 21, 2021
Ichor Therapeutics is now known as Ichor Life Sciences. The new name reflects Ichor Life Sciences’ emphasis on delivering premium preclinical contract research and custom programs in discovery through pharmacology from its R&D facilities in LaFayette...
read more
Tuesday, September 21, 2021
Celsion Corporation, a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, and Hainan Poly Pharm Co, a generics manufacturer dedicated to providing therapeutic-value products and services to patients and customers ...
read more
Tuesday, September 21, 2021
Asymchem announced a strategic partnership agreement to provide LaNova Medicines with one-stop services such as small molecule drugs, ADC project CMCs, R&D, production and IND China-US declaration.
read more
Monday, September 20, 2021
Astrea Bioseparations, a leading provider of bioseparations products and services, announced two new investments to enhance operations and customer support resources. The investments include an expansion of the company’s research and development ...
read more
Wednesday, September 15, 2021
Inotiv, a leading contract research organization (CRO) specializing in nonclinical and analytical drug discovery and development services, and Envigo, a leading global provider of research models and services, jointly announced that they have entered...
read more
Tuesday, September 14, 2021
Naobios, a CDMO providing bioprocess development and GMP production of clinical batches of viral vaccines BSL2/BSL3, oncolytic viruses and viral vectors, announces the next phase in its partnership with FluGen, Inc., a clinical-stage vaccine company ...
read more
Monday, September 13, 2021
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced the appointment of Dr. Christian Schetter, Ph.D. as Chief Scientific Officer (CSO) of Rentschler Biopharma SE, where ...
read more
Wednesday, September 08, 2021
Advarra, the premier provider of independent review committees, quality and compliance consulting services, and research technology solutions, announced today the launch of its Early Phase Center of Excellence, a dedicated suite of services and ...
read more
Wednesday, September 08, 2021
For over 20 years, Formulated Solutions has been driven to create more ideal consumer and patient experiences in Pharmaceutical and Self-Directed Consumer Healthcare. In support of that adherence-focused mission, Formulated Solutions is proud to ...
read more
Wednesday, September 08, 2021
Medable Inc., the leading cloud platform for patient-centered drug development, announced the hiring of Dr. MaryAnne Rizk as Chief Strategy Officer. Rizk is a veteran leader with more than 20 years of experience managing partnerships and ecosystems ...
read more
Wednesday, September 08, 2021
ADMA Biologics, an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced that the FDA has granted approval for the Company’s in-house aseptic fill-finish ...
read more
Wednesday, September 08, 2021
Based in Midland, Michigan, Impact Analytical operates in the pharmaceutical, medical device, consumer product and specialty chemicals segments, with a strong presence in extractables and leachables. The business recently moved into the bio-...
read more
Wednesday, September 08, 2021
Avantor, a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that it has entered into a definitive agreement to acquire the ...
read more